Kewaunee Scientific Corporation
KEQU · NASDAQ
4/30/2025 | 4/30/2024 | 4/30/2023 | 4/30/2022 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.20 | 0.00 | -0.27 | -0.10 |
| FCF Yield | 13.92% | 14.78% | -18.01% | -24.65% |
| EV / EBITDA | 5.53 | 5.02 | 5.99 | 112.29 |
| Quality | ||||
| ROIC | 9.39% | 26.74% | 1.30% | -7.87% |
| Gross Margin | 28.63% | 25.55% | 16.21% | 14.34% |
| Cash Conversion Ratio | 1.28 | 1.04 | -2.79 | 1.31 |
| Growth | ||||
| Revenue 3-Year CAGR | 3.09% | 6.46% | 14.18% | 4.60% |
| Free Cash Flow Growth | -16.94% | 291.37% | 18.94% | -559.46% |
| Safety | ||||
| Net Debt / EBITDA | 1.55 | -0.68 | 0.59 | 68.92 |
| Interest Coverage | 5.53 | 10.16 | 2.09 | -4.13 |
| Efficiency | ||||
| Inventory Turnover | 5.22 | 7.34 | 8.40 | 6.08 |
| Cash Conversion Cycle | 107.06 | 74.51 | 73.23 | 109.37 |